Because the biological effects of estrogen are mediated primarily through its high affinity binding to ERs, genetic variants in ER genes, including ESR1 and ESR2, have been the focus of numerous epidemiologic studies on BC risk [34]–[36]. This evidence concerns the gene ESR2 and breast cancer.